JPRN-UMIN000014305
Completed
未知
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus cancer - DNF-NAC for resectable esophagus cancer
Department of Medical Oncology, Sapporo Medical University School of Medicine0 sites28 target enrollmentJune 18, 2014
Conditionsesophagus cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- esophagus cancer
- Sponsor
- Department of Medical Oncology, Sapporo Medical University School of Medicine
- Enrollment
- 28
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) No prior chemotherapy regimen. (2\) history of drug hypersensitivity. (3\) active concomitant malignancy. (4\) serious complications (severe heart disease, active infection) (5\) pregnant or lactating females. (6\) The investigator considers not suitable for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
Completed
Not Applicable
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20
Completed
Phase 2
Feasibility trial of neoadjuvant chemotherapy with docetaxel,cisplatin and fluorouracil for clinical stage II/III esophageal carcinoma.esophageal neoplasmJPRN-UMIN000002396Saitama Cancer Center40
Recruiting
Not Applicable
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
Completed
Not Applicable
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24